Paricalcitol Generics bulk supplier for pharma manufacturers

Paricalcitol Generics Suppliers & Bulk Manufacturers

Available Forms: Capsules and Injection

Available Strengths: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL

Reference Brands: Zemplar®(US &EU)

Paricalcitol (Zemplar®) is a selective vitamin D receptor activator used to manage secondary hyperparathyroidism in CKD patients, available as oral capsules and IV injection. Approved in both the EU and US, it offers targeted PTH control with a lower risk of hypercalcemia and hyperphosphatemia. Suitable for hospital tenders, licensing, and distribution in the global renal care market.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Paricalcitol, marketed as Zemplar®, is a selective vitamin D receptor activator used to treat secondary hyperparathyroidism in patients with chronic kidney disease (CKD), both on dialysis (stage 5) and in pre-dialysis stages (3–4). It effectively lowers parathyroid hormone (PTH) levels while minimizing the risk of hypercalcemia and hyperphosphatemia. Available as oral capsules (1 mcg, 2 mcg, 4 mcg) and IV injection (2 mcg/mL, 5 mcg/mL), Paricalcitol is approved in both the US (FDA) and EU (EMA). It is a key therapeutic in nephrology and an excellent B2B opportunity for licensing, distribution, and hospital-based partnerships in regulated markets.

Paricalcitol Generics — third party manufacturing & bulk supply

Paricalcitol Generics is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Paricalcitol Generics is supplied as Capsules and Injection — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Paricalcitol Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Paricalcitol Generics →

Back to Listing

Frequently Asked Questions

Paricalcitol Generics is listed as Capsules and Injection in Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Paricalcitol Generics is referenced against Zemplar®(US &EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.